Loss of the Novel Tumour Suppressor and Polarity Gene Trim62 (Dear1) Synergizes with Oncogenic Ras in Invasive Lung Cancer

Overview

Journal J Pathol

Specialty Pathology

Date 2014 Jun 4

PMID 24890125

Citations 17

Authors

Alfonso Quintas-Cardama

Sean M Post

Luisa M Solis

Shunbin Xiong

Peirong Yang

Nanyue Chen

Ignacio I Wistuba

Ann M Killary

Guillermina Lozano

Affiliations

Soon will be listed here.

Abstract

Deregulation of cell polarity proteins has been linked to the processes of invasion and metastasis. TRIM62 is a regulator of cell polarity and a tumour suppressor in breast cancer. Here, we demonstrate that human non-small cell lung cancer lesions show a step-wise loss of TRIM62 levels during disease progression, which was associated with poor clinical outcomes. To directly examine the role of Trim62 in development of lung cancer, we deleted Trim62 in a mutant K-Ras mouse model of lung cancer. In this context, haploinsufficiency of Trim62 synergized with a K-RasG12D mutation to promote invasiveness and disrupt three-dimensional morphogenesis, both of which are associated with epithelial-mesenchymal transitions. Re-expression of Trim62 reverted these phenotypes in tumour cell lines. Thus, Trim62 loss cooperates with K-Ras mutation in tumourigenesis and metastasis in vivo, indicating that decreased levels of TRIM62 may play an important role in the evolution of lung cancer.

Citing Articles

Tripartite motif protein 6 promotes hepatocellular carcinoma progression via multiple pathways.

Zhang Y, Yuan L, Cui S, Wu S Turk J Med Sci. 2024; 53(5):1032-1044.

PMID: 38813007 PMC: 10763761. DOI: 10.55730/1300-0144.5668.

TRIM62 knockdown by inhibiting the TLR4/NF-κB pathway and NLRP3 inflammasome attenuates cognitive impairment induced by diabetes in mice.

Nong X, Li N, Wang X, Li H, Wu X, Li M J Clin Biochem Nutr. 2023; 73(2):131-137.

PMID: 37700852 PMC: 10493211. DOI: 10.3164/jcbn.22-104.

Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape.

Gu J, Chen J, Xiang S, Zhou X, Li J J Adv Res. 2023; 54:147-179.

PMID: 36736694 PMC: 10703639. DOI: 10.1016/j.jare.2023.01.011.

M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62.

Zhang K, Li Y, Peng L, Gao H, Liu L, Chen H Biol Direct. 2023; 18(1):1.

PMID: 36631876 PMC: 9832623. DOI: 10.1186/s13062-023-00356-y.

Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies.

Wang J, Luo Z, Lin L, Sui X, Yu L, Xu C Cancers (Basel). 2022; 14(19).

PMID: 36230714 PMC: 9564242. DOI: 10.3390/cancers14194791.

References

Chen N, Balasenthil S, Reuther J, Frayna A, Wang Y, Chandler D . DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition. Cancer Discov. 2013; 3(10):1172-89. PMC: 4107927. DOI: 10.1158/2159-8290.CD-12-0499. View

Fidler I . The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003; 3(6):453-8. DOI: 10.1038/nrc1098. View

Johnson L, Mercer K, Greenbaum D, Bronson R, Crowley D, Tuveson D . Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 2001; 410(6832):1111-6. DOI: 10.1038/35074129. View

Lott S, Chen N, Chandler D, Yang Q, Wang L, Rodriguez M . DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med. 2009; 6(5):e1000068. PMC: 2673042. DOI: 10.1371/journal.pmed.1000068. View

Cataldo V, Gibbons D, Perez-Soler R, Quintas-Cardama A . Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med. 2011; 364(10):947-55. DOI: 10.1056/NEJMct0807960. View

Short K, Hopwood B, Yi Z, Cox T . MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. BMC Cell Biol. 2002; 3:1. PMC: 64779. DOI: 10.1186/1471-2121-3-1. View

Xiong S, Grijalva R, Zhang L, Nguyen N, Pisters P, Pollock R . Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Cancer Res. 2001; 61(4):1727-32. View

Khetchoumian K, Teletin M, Tisserand J, Mark M, Herquel B, Ignat M . Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat Genet. 2007; 39(12):1500-6. DOI: 10.1038/ng.2007.15. View

Talmadge J, Fidler I . AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010; 70(14):5649-69. PMC: 4037932. DOI: 10.1158/0008-5472.CAN-10-1040. View

10.

Shimazui T, Schalken J, Giroldi L, Jansen C, Akaza H, Koiso K . Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res. 1996; 56(18):4154-8. View

11.

Weber G, Bronson R, Ilagan J, Cantor H, Schmits R, Mak T . Absence of the CD44 gene prevents sarcoma metastasis. Cancer Res. 2002; 62(8):2281-6. View

12.

Borg A, Zhang Q, Olsson H, Wenngren E . Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. Genes Chromosomes Cancer. 1992; 5(4):311-20. DOI: 10.1002/gcc.2870050406. View

13.

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

14.

Tsai W, Wang Z, Yiu T, Akdemir K, Xia W, Winter S . TRIM24 links a non-canonical histone signature to breast cancer. Nature. 2010; 468(7326):927-32. PMC: 3058826. DOI: 10.1038/nature09542. View

15.

Yu Q, Toole B, Stamenkovic I . Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med. 1998; 186(12):1985-96. PMC: 2199167. DOI: 10.1084/jem.186.12.1985. View

16.

Kedar V, McDonough H, Arya R, Li H, Rockman H, Patterson C . Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci U S A. 2004; 101(52):18135-40. PMC: 539735. DOI: 10.1073/pnas.0404341102. View

17.

Kumar M, Erkeland S, Pester R, Chen C, Ebert M, Sharp P . Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A. 2008; 105(10):3903-8. PMC: 2268826. DOI: 10.1073/pnas.0712321105. View

18.

Zhan L, Rosenberg A, Bergami K, Yu M, Xuan Z, Jaffe A . Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell. 2008; 135(5):865-78. PMC: 3015046. DOI: 10.1016/j.cell.2008.09.045. View

19.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

20.

Debnath J, Mills K, Collins N, Reginato M, Muthuswamy S, Brugge J . The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell. 2002; 111(1):29-40. DOI: 10.1016/s0092-8674(02)01001-2. View